This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Lithuania, Netherlands, Romania, United Kingdom, South Africa
The drug OSVAREN contains a combination of these active pharmaceutical ingredients (APIs):
1
Calcium acetate
UNII Y882YXF34X - CALCIUM ACETATE
|
Calcium is an endogenous ion of the body essential for the maintenance of a number of physiologic processes. It participates as an integral factor in the maintenance of the functional integrity of the nervous system, in the contractile mechanisms of muscle tissue, in the clotting of blood, and in the formation of the major structural material of the skeleton. Soluble calcium salts are commonly used in the treatment of calcium deficiency. |
2
Magnesium carbonate heavy
UNII 0E53J927NA - MAGNESIUM CARBONATE
|
Magnesium carbonate, MgCO3 (archaic name magnesia alba), is an inorganic salt. The most common magnesium carbonate forms are the anhydrous salt called magnesite (MgCO3) and the di, tri, and pentahydrates known as barringtonite (MgCO3·2 H2O), nesquehonite (MgCO3·3 H2O), and lansfordite (MgCO3·5 H2O), respectively. The primary use of magnesium carbonate is the production of magnesium oxide by calcining. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
OSVAREN Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
V03AE04 | Calcium acetate and magnesium carbonate | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1287592 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 69670 |
Country: FR | Base de données publique des médicaments | Identifier(s): 68613807 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 151790 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-130861711 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1028126, 1080796 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 98167 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W59601001 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 45/24/0919 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.